The work of Perou and Sorlie allowed the subdivision of breast cancers in five subtypes, distinguished by differences in their gene expression patterns with distinct clinical behaviors: basal, erb-b2 receptor tyrosine kinase 2 (ERBB/HER2), luminal A, luminal B, and normal breast-like [1,2]. This evidence concerns the gene ERBB2 and breast cancer.